Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT07386444
- Status
- Recruiting
Conditions
- Dyspnea
- Early Stage Breast Carcinoma
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Inspiratory muscle training — BEHAVIORALTraining of respiratory muscles
Study Details
This clinical trial studies whether breathing exercises for the muscles that help with breathing air in, inspiratory muscle training (IMT), works to improve breathing muscle strength, shortness of breath, and physical activity levels in women who are receiving chemotherapy for early-stage breast cancer (BC). Cancer and/or treatments for BC can directly result in muscle wasting that involves breathing muscles, skeletal muscles or heart muscles. Pain, weakness, shortness of breath, and side effects of cancer treatment may lead to lower physical activity levels. IMT involves breathing exercises using a small hand-held device. The device makes it a little harder to breathe in, which may help strengthen breathing muscles. IMT may be an effective way to improve breathing muscle strength, shortness of breath, and physical activity levels in women who are receiving chemotherapy for early-stage BC.
Key Dates
- Start date
- Feb 16, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 58 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Arm 1 (low-intensity IMT)Patients complete three sets of fifteen repetitions per session of low-intensity IMT over 15-20 minutes four days a week for 8 weeks.
- Experimental: Arm 2 (high-intensity IMT)Patients complete three sets of fifteen repetitions per session of high-intensity IMT over 15-20 minutes four days a week for 8 weeks.
Primary Outcome Measure
Maximum inspiratory pressure [ Time Frame: Baseline to 8 weeks ]
Central Contacts
- The Ohio State University Comprehensive Cancer Center800-293-5066
- Dharini Bhammar614-366-9467
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | Dharini M. Bhammar, MBBS, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
Related Studies
- Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast CancerRecruiting · Mayo Clinic · Scottsdale, Arizona
- Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 InfectionRecruiting · Tufts Medical Center · Boston, Massachusetts
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PHPHASE2 · Recruiting · VA Office of Research and Development · Aurora, Colorado
- 129Xe MRI CardiopulmonaryPHASE2 · Recruiting · Bastiaan Driehuys · Durham, North Carolina